BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 209591)

  • 1. Serum albumin and total globulin levels in common liver diseases in Accra (Ghana).
    Fenuku RI; Foli AK
    Trop Geogr Med; 1978 Mar; 30(1):87-90. PubMed ID: 209591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
    Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum globulin subfraction variations in liver cirrhosis and hepatoma.
    Kageyama T; Kimoto S; Toda H; Oyabu H; Watanabe I
    Bull Osaka Med Sch; 1975 Oct; 21(2):132-9. PubMed ID: 181107
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum proteins in hepatic disease.
    Teloh HA
    Ann Clin Lab Sci; 1978; 8(2):127-9. PubMed ID: 637517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte 2,3-diphosphoglycerate in liver diseases.
    Nakano T; Fujioka H; Tamura S; Amuro Y; Nabeshima K; Hada T; Higashino K
    Am J Gastroenterol; 1987 Dec; 82(12):1283-6. PubMed ID: 2825516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases.
    Lin CC; Huang JF; Tsai LY; Huang YL
    Biol Trace Elem Res; 2006 Jan; 109(1):15-24. PubMed ID: 16388099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum concentration of alpha 1-antitrypsin in various hepatic diseases].
    Villamil F; Galli B; Sorroche P; Occello M; Gelpi J; Welz G
    Medicina (B Aires); 1986; 46(2):139-42. PubMed ID: 3033426
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma.
    Huang MJ; Liaw YF
    Am J Gastroenterol; 1990 Mar; 85(3):281-4. PubMed ID: 1689951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum calcitonin levels in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Sagara K; Sato T
    Horm Metab Res; 1986 Jun; 18(6):421-2. PubMed ID: 3015758
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.
    Uehara M; Sato N
    Hepatology; 1994 Aug; 20(2):326-30. PubMed ID: 8045492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminant analysis of biochemical parameters in liver disease.
    Olubuyide IO; Festing MF; Chapman C; Higginson J; Whicher JT
    Trop Gastroenterol; 1997; 18(1):15-9. PubMed ID: 9197166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The level of IL-8 in the serum of patients suffering from chronic hepatic diseases and primary hepatocellular carcinoma].
    Tong L; Zhu L; Fan Y; Lu B
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):432-3. PubMed ID: 12502445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O; Watanabe A; Minemura M; Tsuchida T
    J Med; 1993; 24(1):35-46. PubMed ID: 7684768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum testosterone: a special feature of hepatocellular carcinoma.
    Lampropoulou-Karatzas C; Goritsas P; Makri MG
    Eur J Med; 1993 Jan; 2(1):23-7. PubMed ID: 8258001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.